ArticleGeburtshilfe und Frauenheilkunde2026
Sexual Distress Scale: Translation, Psychometric Validation, and Reference Values for Cisgender Women and Men in a Representative Population-based Sample in Germany.
Article in Geburtshilfe und Frauenheilkunde, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sexual dysfunction is common but often remains undetected in gynecological care. Validated instruments can support accurate and efficient diagnosis, especially under time constraints and limited patient contact. The Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO) is an internationally validated instrument to assess sexual distress, the core diagnostic criterion for sexual dysfunction according to ICD-11. This study aimed to i) validate the factor structure of the German FSDS-DAO questionnaire, ii) examine its applicability in cisgender women and men, and iii) determine a clinically relevant cutoff score. Methods: The German version was developed using a standardized translation process and extended by a 16th item assessing distress due to pain during sexual activity. Validation was based on a representative German sample from a population survey on persons seeking help for sexual dysfunction (N = 4023). Cisgender women and men were matched using propensity scores based on sociodemographic characteristics. Confirmatory factor analysis and measurement invariance testing were conducted in the matched sample (N = 2829). A ROC analysis using an ICD-11 screening tool was performed in the full sample (N = 4023) to determine a clinically relevant cutoff. Results: The proposed factor structure was confirmed. Partial strict measurement invariance between women and men was observed, with one item showing group-specific properties. Overall, men reported slightly higher sexual distress (d = 0.13). A clinically relevant cutoff of 16 (AUC = 0.89) was identified with high diagnostic accuracy. Conclusion: With 16 items and a validated cutoff score of 16, the German version of the FSDS-DAO represents a practical screening instrument for use in the care of both women and men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.